Reiterative Radiofrequency Ablation in the Management of Pediatric Patients with Hepatoblastoma Metastases to the Lung, Liver, or Bone

2018 ◽  
Vol 42 (1) ◽  
pp. 41-47 ◽  
Author(s):  
Steven Yevich ◽  
Marco Calandri ◽  
Guillaume Gravel ◽  
Brice Fresneau ◽  
Laurence Brugières ◽  
...  
Author(s):  
Christian Calvo-Henriquez ◽  
Franklin Mariño-Sánchez ◽  
Jerome R. Lechien ◽  
Byron Maldonado Alvarado ◽  
Antonino Maniaci ◽  
...  

1995 ◽  
Vol 75 (8) ◽  
pp. 587-590 ◽  
Author(s):  
David A. Danford ◽  
◽  
John D. Kugler ◽  
Barbara Deal ◽  
Christopher Case ◽  
...  

2016 ◽  
Vol 37 (8) ◽  
pp. 1534-1538 ◽  
Author(s):  
Philip L. Wackel ◽  
Andrew W. McCrary ◽  
Salim F. Idriss ◽  
Samuel J. Asirvatham ◽  
Bryan C. Cannon

2007 ◽  
Vol 37 (3) ◽  
pp. 297-300 ◽  
Author(s):  
Fredric A. Hoffer ◽  
Alvaro Campos ◽  
Xiaoping Xiong ◽  
Shengjie Wu ◽  
Nikita Oigbokie ◽  
...  

2021 ◽  
Vol 9 ◽  
Author(s):  
An-Ni Lin ◽  
Wei-Che Lin ◽  
Kai-Lun Cheng ◽  
Sheng-Dean Luo ◽  
Pi-Ling Chiang ◽  
...  

Purpose: To evaluate the effectiveness of radiofrequency ablation (RFA) for benign thyroid nodules in pediatric patients.Materials and Methods: Twelve pediatric patients (11 female, 1 male; mean age 15.54 ± 2.8 years, range 10–19 years) with benign thyroid nodules (mean longest diameter 4.1 ± 1.4 cm, range 1.5–5.9 cm) treated by RFA from 2017 to 2020 were evaluated. The inclusion criteria for RFA therapy were (i) age < 20 years; (ii) benign cytological confirmation by 2 separate ultrasound guided fine-needle aspiration cytology (FNAC) or core needle biopsies; (iii) pressure symptoms or cosmetic problems caused by thyroid nodules; (iv) absence of any sonographic suspicious feature; and (v) follow-up for >6 months. Under local anesthesia, RFA was performed with the use of an RF generator and an 18-gauge internally cooled electrode. Volume changes in nodules on follow-up ultrasonography (US), changes in symptomatic and cosmetic scores, and complications arising during or after RFA were evaluated.Results: Mean follow-up period was 24.9 ± 13.9 months (range 6–43 months). At the last follow-up visits, volume of the nodule had decreased significantly (15.34 ± 11.52 mL vs. 4.07 ± 4.99 mL; P < 0.05), whereas volume reduction rate was 74.31% ± 19.59%. Both cosmetic and compressive symptoms were also significantly improved (2.91 ± 0.79 vs. 0.92 ± 0.67 and 1.5 ± 1.93 vs. 0.17 ± 0.39; P < 0.05). The mean number of ablation sessions was 1.4 ± 0.6 (range 1–3 sessions), and one of the patients suffered from transient vocal cord palsy which was spontaneously resolved 53 days later.Conclusions: RFA is a safe and effective treatment for benign thyroid nodules in pediatric patients, and can thus serve as an alternative treatment for thyroidectomy.


Author(s):  
Francesco Fiore ◽  
Francesco Somma ◽  
Roberto D’Angelo ◽  
Luca Tarotto ◽  
Vincenzo Stoia

Abstract Purpose To assess efficacy and safety of cone beam computed tomography (CBCT) in the radiofrequency ablation (RFA) of osteoid osteoma (OO) in children and adolescents, and to compare technical success, clinical success, radiation dose and procedure duration time of CBCT guidance to conventional computed tomography (CT) guidance. Materials and methods Between 2015 and 2019, 53 consecutive percutaneous RFA were performed on pediatric patients with CBCT or conventional CT guidance, respectively, in 24 and 29 children and adolescents with 24-month follow-up. Dose area product (DAP) and dose length product (DLP) were recorded, respectively, for CBCT and conventional CT and converted to effective doses (ED). Results CBCT and conventional CT groups were similar in terms of patient age and weight, tumor size and tumor location. Technical success was achieved in all cases. Primary clinical success was 91.67% (22/24) for the CBCT group and 89.66% (26/29) for the conventional CT group. Mean DAP was 64.75Gycm2 (range 6.0–266.7). Mean DLP was 972.62mGycm (range 337–2344). ED was significantly lower in the CBCT group compared to the conventional CT group (0.34 mSv vs. 5.53 mSv, p = 0.0119). Procedure duration time was not significantly longer in the CBCT group (102.25 min vs. 92.34 min, p = 0.065). No major complication was registered. Minor complications were observed in 4 patients (2 in CBCT; 2 in conventional CT). Conclusions Compared to conventional CT guidance, CBCT guidance for percutaneous OO ablation shows similar technical and clinical success rates, with reduced radiation dose and equivalent procedure duration time. This technique helps sparing dose exposure to pediatric patients.


2020 ◽  
Author(s):  
Gabriela I. Pereira-López ◽  
Carlos R. Sierra-Fernández ◽  
Santiago R. Nava-Townsend ◽  
Juan E. Calderón-Colmenero ◽  
Alfonso Buendía-Hernández ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document